DB12871InvestigationalProtein Based Therapies
Burlulipase has been used in trials studying the treatment of Lung Diseases, Cystic Fibrosis, Pancreatic Insufficiency, Digestive System Diseases, and Respiratory Tract Diseases.
Resolves to
Compound
What you can answer from here — as of February 21, 2021
Which companies are running trials of Burlulipase, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account